Brief: Orchestra Biomed Receives FDA Breakthrough Device Designation For Avim Therapy
22/04/2025 12:31
April 22 (Reuters) - Medtronic PLC MDT.N: ORCHESTRA BIOMED RECEIVES FDA BREAKTHROUGH DEVICE DESIGNATION FOR AVIM THERAPY Source text: ID:nGNX21k9Q1 Further company coverage: MDT.N
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens